By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ironwood Pharmaceuticals 

301 Binney Street

Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-621-7722 Fax: 617-494-0480


Ironwood Pharmaceuticals (NASDAQ: IRWD) is focused on creating medicines that make a difference for patients, building value to earn the continued support of our fellow shareholders, and empowering our team to passionately pursue excellence. We discovered, developed and are commercializing linaclotide, which is approved in the United States and a number of other countries. Our pipeline priorities include exploring further opportunities for linaclotide, as well as leveraging our therapeutic expertise in gastrointestinal disorders and our pharmacologic expertise in guanylate cyclases to address patient needs across the upper and lower gastrointestinal tract. Ironwood was founded in 1998 and is headquartered in Cambridge, Mass. Connect with us at or on Twitter at

Key Statistics

Ownership: Public

Web Site: Ironwood
Symbol: IRWD


Company News
Ironwood (IRWD) To Host Third Quarter 2016 Investor Update Call 10/21/2016 9:03:43 AM
Ironwood (IRWD) Announces U.S. Availability Of ZURAMPIC (lesinurad) 200 mg Tablets For Patients With Uncontrolled Gout 10/3/2016 10:58:37 AM
Ironwood (IRWD) Release: Nine In Ten Physicians Agree Target Goal For Gout Is Imperative, Yet Half Of Patients Fail To Reach It, New Survey Shows 10/3/2016 8:46:16 AM
Ironwood (IRWD) Closes $150 Million Debt Refinancing 9/26/2016 8:36:23 AM
Ironwood (IRWD) To Present At Morgan Stanley (MST) Global Healthcare Conference 9/7/2016 10:37:03 AM
Ironwood (IRWD) To Present At Wells Fargo 2016 Healthcare Conference 9/2/2016 9:21:49 AM
Ironwood (IRWD) Provides Second Quarter 2016 Investor Update 8/5/2016 10:49:04 AM
Ironwood (IRWD) To Host Second Quarter 2016 Investor Update Call 7/22/2016 7:41:49 AM
Ironwood (IRWD) And Allergan (AGN) Announce Supplemental New Drug Application For 72 Mcg Linaclotide In Chronic Idiopathic Constipation Has Been Accepted For FDA Review 6/9/2016 9:04:08 AM
Ironwood (IRWD) To Present At Jefferies 2016 Healthcare Conference 6/6/2016 2:33:38 PM